Catechol- O -methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior
Open accessAbstract
Catechol- O -methyltransferase (COMT) is one of the major mammalian enzymes involved in the metabolic degradation of catecholamines and is considered a candidate for several psychiatric disorders and symptoms, including the psychopathology associated with the 22q11 microdeletion syndrome. By means of homologous recombination in embryonic stem cells, a strain of mice in which the gene encoding the COMT enzyme has been disrupted was produced. The basal concentrations of brain catecholamines were measured in the striatum, frontal cortex, and hypothalamus of adult male and female mutants. Locomotor activity, anxiety-like behaviors, sensorimotor gating, and aggressive behavior also were analyzed. Mutant mice demonstrated sexually dimorphic and region-specific changes of dopamine levels, notably in the frontal cortex. In addition, homozygous COMT-deficient female (but not male) mice displayed impairment in emotional reactivity in the dark/light exploratory model of anxiety. Furthermore, heterozygous COMT-deficient male mice exhibited increased aggressive behavior. Our results provide conclusive evidence for an important sex- and region-specific contribution of COMT in the maintenance of steady-state levels of catecholamines in the brain and suggest a role for COMT in some aspects of emotional and social behavior in mice.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The role of COMT in aggression was initially supported by observations of hostility in mice deficient in Comt and the negative correlation between COMT levels and hostility in men with behavioral problems as children.
“The role of COMT in aggression was initially supported by observations of hostility in mice deficient in Comt and the negative correlation between COMT levels and hostility in men with behavioral problems as children [57, 58]; reviewed in Qayyum et al. (2015) [59].”
From Genetics of child aggression, a systematic review (2024) · cites this paper as [57]
When early life stress is not taken into account, findings on the relationship between MAOA or COMT and aggression or alcohol use are mixed.
“When early life stress is not taken into account, however, the findings on the relationship between MAOA or COMT and aggression or alcohol use are mixed (Gogos et al. 1998; Bortolato et al. 2011; Ficks And Waldman 2014; Qayyum et al. 2015; Lovallo et al. 2019; Godar et al. 2019; Kaya et al. 2021).”
From Decoding the bidirectional links between alcohol misuse and aggression: toward a unified translational framework (2026) · cites this paper as Gogos et al. 1998
COMTVal158Met is differentially expressed across genders.
“This is consistent with evidence that COMTVal158Met is differentially expressed across genders (Dempster et al, 2006; Gogos et al, 1998).”
From DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls (2010) · cites this paper as Gogos et al, 1998
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859 · see citing works
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258 · see citing works
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476 · see citing works
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788 · see citing works
Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
Crawley, J. N., & Goodwin, F. K. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90067-2 · Cited by 1,432 · see citing works
Aggressive Behavior and Altered Amounts of Brain Serotonin and Norepinephrine in Mice Lacking MAOA
Cases, O., Seif, I., Grimsby, J. S., Gaspar, P., Chen, K., Vandormael‐Pournin, S., Müller, U., Aguet, M., Babinet, C., Shih, J. C., et al. (1995) · Science · doi:10.1126/science.7792602 · Cited by 1,225 · see citing works
Assessing the Validity of an Animal Model of Deficient Sensorimotor Gating in Schizophrenic Patients
Swerdlow, N. R. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020063007 · Cited by 708 · see citing works
The helix-loop-helix gene E2A is required for B cell formation
Zhuang, Y. (1994) · Cell · doi:10.1016/0092-8674(94)90076-0 · Cited by 675 · see citing works
Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11.
Karayiorgou, M., Morris, M. A., Morrow, B., Shprintzen, R. J., Goldberg, R., Borrow, J., Gos, A., Nestadt, G., Wolyniec, P. S., & Lasseter, V. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7612 · Cited by 628 · see citing works
Self-citationHaloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder
McDougle, C. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040046006 · Cited by 574 · see citing works
Efficacy and Tolerability of Serotonin Transport Inhibitors in Obsessive-compulsive Disorder
Greist, J. H. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950130053006 · Cited by 498 · see citing works
Cerebral glucose metabolic rates in obsessive compulsive disorder
NORDAHL, T. E. (1989) · Neuropsychopharmacology · doi:10.1016/0893-133x(89)90003-1 · Cited by 389 · see citing works
Inbred strain differences in prepulse inhibition of the mouse startle response
Paylor, R. E., & Crawley, J. N. (1997) · Psychopharmacology · doi:10.1007/s002130050333 · Cited by 382 · see citing works
Papolos, D. F., Faedda, G. L., Veit, S., Goldberg, R. B., Morrow, B. E., Kucherlapati, R., & Shprintzen, R. J. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1541 · Cited by 357 · see citing works
A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder
Swerdlow, N. R., Benbow, C. H., Zisook, S., Geyer, M. A., & BRAFF, D. L. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90300-3 · Cited by 351 · see citing works
Karoum, F., Chrapusta, S. J., & Egan, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030972.x · Cited by 347 · see citing works
Information-processing deficits and thought disorder in schizophrenia
Perry, W., & BRAFF, D. L. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.363 · Cited by 311 · see citing works
Karayiorgou, M., Altemus, M., Galke, B. L., Goldman, D., Murphy, D. L., Ott, J., & Gogos, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4572 · Cited by 304 · see citing works
Self-citationChen, C., Rainnie, D. G., Greene, R. W., & Tonegawa, S. (1994) · Science · doi:10.1126/science.7939668 · Cited by 286 · see citing works
Increased stress response and β–phenylethylamine in MAOB–deficient mice
Grimsby, J. S., Tóth, M., Chen, K., Kumazawa, T., Klaidman, L. K., Adams, J. D., Jr., Karoum, F., Gál, J., & Shih, J. C. (1997) · Nature Genetics · doi:10.1038/ng1097-206 · Cited by 258 · see citing works
Human liver catechol-O-methyltransferase pharmacogenetics
Boudíková, B., Szumlanski, C. L., Maidak, B. L., & Weinshilboum, R. M. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.166 · Cited by 248 · see citing works
Strous, R. D., Bark, N. M., Parsia, S. S., Volavka, J., & Lachman, H. M. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(96)03111-3 · Cited by 217 · see citing works
Mathis, C., Paul, S. M., & Crawley, J. N. (1994) · Behavior Genetics · doi:10.1007/bf01067821 · Cited by 111 · see citing works
Karayiorgou, M., Gogos, J. A., Galke, B. L., Wolyniec, P. S., Nestadt, G., Antonarakis, S. E., Kazazian, H. H., Housman, D. E., & Pulver, A. E. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00202-3 · Cited by 107 · see citing works
Self-citationLi, T., Vallada, H., Curtis, D., Arranz, M. J., Xu, K., Cai, G., Deng, H., Liu, J., Murray, R. M., Liu, X., et al. (1997) · Pharmacogenetics · doi:10.1097/00008571-199710000-00002 · Cited by 91 · see citing works
Mathis, C., Neumann, P. E., Gershenfeld, H. K., Paul, S. M., & Crawley, J. N. (1995) · Behavior Genetics · doi:10.1007/bf02327579 · Cited by 91 · see citing works
Crusio, W. E., Schwegler, H., & van Abeelen, J. H. F. (1989) · Behavioural Brain Research · doi:10.1016/s0166-4328(89)80074-9 · Cited by 88 · see citing works
Renner, K. J., & Luine, V. N. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90320-5 · Cited by 84 · see citing works
Self-citationErythrocyte Soluble Catechol-O-Methyl Transferase Activity in Primary Affective Disorder
Gershon, E. S. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760290019001 · Cited by 77 · see citing works
The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission.
Napolitano, A., Cesura, A. M., & Prada, M. D. (1995) · PubMed · Cited by 75 · see citing works
Kaakkola, S., & Wurtman, R. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05831.x · Cited by 66 · see citing works
ApoE genotype is a risk factor in nonpresenilin early-onset alzheimer's disease families
Houlden, H., Crook, R., Backhovens, H., Prihar, G., Baker, M. C., Hutton, M., Rossor, M. N., Martin, J. J., Broeckhoven, C. V., & Hardy, J. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980207)81:1 · Cited by 64 · see citing works
The effect of estradiol on catechol-O-methyltransferase activity in rat liver
Cohn, C. K., & Axelrod, J. (1971) · Life Sciences · doi:10.1016/0024-3205(71)90335-3 · Cited by 49 · see citing works
Do animal models have a place in the genetic analysis of quantitative human behavioural traits?
Flint, J., & Corley, R. P. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00204977 · Cited by 42 · see citing works
Griebel, G., Sanger, D. J., & Perrault, G. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00080-9 · Cited by 40 · see citing works
PD135158, a CCK-B antagonist, reduces “state,” but not “trait” anxiety in mice
Belzung, C., Pineau, N., Beuzen, A., & Misslin, R. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90445-6 · Cited by 39 · see citing works
Grossman, M. H., Szumlanski, C. L., Littrell, J. B., Weinstein, R. S., & Weinshilboum, R. M. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90386-4 · Cited by 31 · see citing works
The interstimulus interval and classical conditioning in the marine snail Hermissenda crassicornis
Lederhendler, I., & Alkon, D. L. (1989) · Behavioural Brain Research · doi:10.1016/s0166-4328(89)80010-5 · Cited by 23 · see citing works
Puźyński, S., Bidziński, A., Mrozek, S., & Załuska, M. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb06728.x · Cited by 22 · see citing works
Collier, D. A., & Sham, P. C. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000274 · Cited by 10 · see citing works
Changes in hypothalamic catechol-O-methyl-transferase during sexual differentiation of the brain.
Ladosky, W., & Schneider, H. T. (1981) · PubMed · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · see citing works
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,374 · see citing works
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020 · see citing works
The hippocampal-VTA loop: controlling the entry of information into long-term memory
Lisman, J. E., & Grace, A. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.002 · Cited by 1,983 · see citing works
Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/425589 · Cited by 1,675 · see citing works
Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control
Cools, R., & D'Esposito, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.028 · Cited by 1,673 · see citing works
DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1
Jerome, L. A., & Papaioannou, V. E. (2001) · Nature Genetics · doi:10.1038/85845 · Cited by 1,076 · see citing works
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068 · see citing works
Candidate gene studies of ADHD: a meta-analytic review
Gizer, I. R., Ficks, C., & Waldman, I. D. (2009) · Human Genetics · doi:10.1007/s00439-009-0694-x · Cited by 1,020 · see citing works
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988 · see citing works
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Williams‐Gray, C. H., Evans, J., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., et al. (2009) · Brain · doi:10.1093/brain/awp245 · Cited by 970 · see citing works
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 963 · see citing works
Measuring normal and pathological anxiety-like behaviour in mice: a review
Belzung, C., & Griebel, G. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00291-1 · Cited by 912 · see citing works
Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931309100 · Cited by 893 · see citing works
Bilder, R. M., Volavka, J., Lachman, H. M., & Grace, A. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300542 · Cited by 769 · see citing works
The correlative triad among aging, dopamine, and cognition: Current status and future prospects
Bäckman, L., Nyberg, L. H., Lindenberger, U., Li, S., & Farde, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.06.005 · Cited by 761 · see citing works
Prefrontal neurons and the genetics of schizophrenia
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F., & Goldberg, T. E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01252-5 · Cited by 744 · see citing works
A Highly Significant Association between a COMT Haplotype and Schizophrenia
Shifman, S., Bronstein, M., Sternfeld, M., Pisanté, A., Lev-Lehman, E., Weizman, A., Reznik, I., Spivak, B., Grisaru, N., Karp, L., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/344514 · Cited by 691 · see citing works
Catechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond
Tunbridge, E. M., Harrison, P. J., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.024 · Cited by 685 · see citing works
Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning
Frank, M. J., Moustafa, A. A., Haughey, H. M., Curran, T., & Hutchison, K. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706111104 · Cited by 669 · see citing works
Schizophrenia: Diverse Approaches to a Complex Disease
Sawa, A., & Snyder, S. H. (2002) · Science · doi:10.1126/science.1070532 · Cited by 599 · see citing works
Genes for schizophrenia? Recent findings and their pathophysiological implications
Harrison, P. J., & Owen, M. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12379-3 · Cited by 597 · see citing works
Durstewitz, D., & Seamans, J. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.015 · Cited by 586 · see citing works
Executive Subprocesses in Working Memory
Goldberg, T. E., Egan, M. F., Gscheidle, T., Coppola, R., Weickert, T. W., Kolachana, B. S., Goldman, D. A., & Weinberger, D. R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.9.889 · Cited by 580 · see citing works
Catecholaminergic systems in stress: structural and molecular genetic approaches
Kvetnansky, R., Sabban, E. L., & Palkovits, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00042.2006 · Cited by 548 · see citing works
22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia
Karayiorgou, M., Simon, T. J., & Gogos, J. A. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2841 · Cited by 474 · see citing works
Self-citationFrank, M. J., Doll, B. B., Oas-Terpstra, J., & Moreno, F. (2009) · Nature Neuroscience · doi:10.1038/nn.2342 · Cited by 452 · see citing works
Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype
Meyer-Lindenberg, A., Kohn, P. D., Kolachana, B., Kippenhan, S., McInerney-Leo, A., Nussbaum, R., Weinberger, D. R., & Berman, K. F. (2005) · Nature Neuroscience · doi:10.1038/nn1438 · Cited by 428 · see citing works
Sex differences in animal models of psychiatric disorders
Kokras, N., & Dalla, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12710 · Cited by 418 · see citing works
Tunbridge, E. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1124-04.2004 · Cited by 418 · see citing works
Collins, A. G. E., & Frank, M. J. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07980.x · Cited by 419 · see citing works
Smolka, M. N., Schumann, G., Wrase, J., Grüsser, S. M., Flor, H., Mann, K. F., Braus, D. F., Goldman, D. A., Büchel, C., & Heinz, A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1792-04.2005 · Cited by 416 · see citing works
50 years of hurdles and hope in anxiolytic drug discovery
Griebel, G., & Holmes, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4075 · Cited by 414 · see citing works
Barnett, J. H., Scoriels, L., & Munafò, M. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.005 · Cited by 412 · see citing works
Cristofori, I., Cohen-Zimerman, S., & Grafman, J. (2019) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-804281-6.00011-2 · Cited by 124 · see citing works
Drabant, E. M., Hariri, A. R., Meyer‐Lindenberg, A., Muñoz, K. E., Mattay, V. S., Kolachana, B. S., Egan, M. F., & Weinberger, D. R. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1396 · Cited by 383 · see citing works
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia
Kanasaki, K., Palmsten, K., Sugimoto, H., Ahmad, S., Hamano, Y., Xie, L., Parry, S., Augustin, H. G., Gattone, V. H., Folkman, J., et al. (2008) · Nature · doi:10.1038/nature06951 · Cited by 381 · see citing works
Paylor, R. E., Pourcain, B. S., Mupo, A., Ataliotis, P., Spencer, C. M., Sobotka, A., Sparks, C., Choi, C.-H., Oghalai, J. S., Curran, S. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600206103 · Cited by 381 · see citing works
Matsumoto, M., Weickert, C. S., Akil, M., Lipska, B. K., Hyde, T. M., Herman, M. M., Kleinman, J. E., & Weinberger, D. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00556-0 · Cited by 365 · see citing works
Genes and the parsing of cognitive processes
Goldberg, T. E., & Weinberger, D. R. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.05.011 · Cited by 356 · see citing works
Dopamine supersensitivity correlates with D2 High states, implying many paths to psychosis
Seeman, P. M., Weinshenker, D., Quirion, R., Srivastava, L. K., Bhardwaj, S. K., Grandy, D. K., Premont, R. T., Sotnikova, T. D., Boksa, P., El-Ghundi, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409766102 · Cited by 353 · see citing works
van den Buuse, M. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp132 · Cited by 340 · see citing works
Forming beliefs: Why valence matters
Sharot, T., & Garrett, N. (2016) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.11.002 · Cited by 345 · see citing works
Assessing the molecular genetics of attention networks
Fossella, J., Sommer, T., Fan, J., Wu, Y., Swanson, J. M., Pfaff, D. W., & Posner, M. I. (2002) · BMC Neuroscience · doi:10.1186/1471-2202-3-14 · Cited by 339 · see citing works
Self-citationCatechol- <i>O</i> -Methyltransferase Genotype and Dopamine Regulation in the Human Brain
Akil, M., Kolachana, B. S., Rothmond, D. A., Hyde, T. M., Weinberger, D. R., & Kleinman, J. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02008.2003 · Cited by 325 · see citing works
COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome
Gothelf, D., D, S. E. M., Thompson, T., Hinard, C., Penniman, L. C., Feinstein, C., Kwon, H., Jin, S., Jo, B., Antonarakis, S. E., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1572 · Cited by 318 · see citing works
From maps to mechanisms through neuroimaging of schizophrenia
Meyer‐Lindenberg, A. (2010) · Nature · doi:10.1038/nature09569 · Cited by 314 · see citing works
The age of anxiety: role of animal models of anxiolytic action in drug discovery
Cryan, J. F., & Sweeney, F. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01362.x · Cited by 313 · see citing works
Harrison, P. J., & Tunbridge, E. M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301543 · Cited by 308 · see citing works
Escalated aggressive behavior: Dopamine, serotonin and GABA
de Almeida, R. M. M., Ferrari, P. F., Parmigiani, S., & Miczek, K. A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.004 · Cited by 303 · see citing works
The gene encoding proline dehydrogenase modulates sensorimotor gating in mice
Gogos, J. A., Sántha, M., Takacs, Z., Beck, K. D., Luine, V. N., Lucas, L., Nadler, J. V., & Karayiorgou, M. (1999) · Nature Genetics · doi:10.1038/7777 · Cited by 296 · see citing works
Self-citationBlasi, G., Mattay, V. S., Bertolino, A., Elvevåg, B., Callicott, J. H., Das, S., Kolachana, B. S., Egan, M. F., Goldberg, T. E., & Weinberger, D. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0476-05.2005 · Cited by 294 · see citing works
Mouse genetic models for prepulse inhibition: an early review
Geyer, M. A., McIlwain, K. L., & Paylor, R. E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001159 · Cited by 289 · see citing works
Bertolino, A., Caforio, G., Blasi, G., Candia, M. D., Latorre, V., Petruzzella, V., Altamura, M., Nappi, G., Papa, S., Callicott, J. H., et al. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1798 · Cited by 287 · see citing works
Neurobehavioral evidence for changes in dopamine system activity during adolescence
Wahlstrom, D., White, T., & Luciana, M. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.007 · Cited by 277 · see citing works
“Conversely, COMT catalyzes catecholamines and appears to be most important in the PFC (Gogos et al., 1998), since COMT knockout mice exhibit increases in PFC DA despite unchanged striatal levels.”
BackgroundGatt, J. M., Burton, K., Williams, L. M., & Schofield, P. R. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.09.014 · Cited by 281 · see citing works
Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia
Abi‐Dargham, A., & Moore, H. M. (2003) · The Neuroscientist · doi:10.1177/1073858403252674 · Cited by 275 · see citing works
The Genetic Basis of Addictive Disorders
Ducci, F., & Goldman, D. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.03.010 · Cited by 303 · see citing works
Barnett, J. H., Jones, P. B., Robbins, T. W., & Müller, U. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001973 · Cited by 274 · see citing works
Cognitive Effects of Nicotine: Recent Progress
Valentine, G. W., & Sofuoglu, M. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666171103152136 · Cited by 280 · see citing works
Yavich, L., Forsberg, M., Karayiorgou, M., Gogos, J. A., & Männistö, P. T. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0665-07.2007 · Cited by 269 · see citing works
Self-citationEnoch, M., Xu, K., Ferro, E., Harris, C. R., & Goldman, D. A. (2003) · Psychiatric Genetics · doi:10.1097/00041444-200303000-00006 · Cited by 267 · see citing works
Karayiorgou, M., Sobin, C. A., Blundell, M. L., Galke, B. L., Malinova, L., Goldberg, P. H., Ott, J., & Gogos, J. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00319-9 · Cited by 263 · see citing works
Self-citationChromosomal microdeletions: dissecting del22q11 syndrome
Lindsay, E. A. (2001) · Nature Reviews Genetics · doi:10.1038/35098574 · Cited by 261 · see citing works
Toward a molecular architecture of personality
Reif, A., & Lesch, K. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00267-x · Cited by 253 · see citing works
Papaleo, F., Crawley, J. N., Song, J., Lipska, B. K., Pickel, J., Weinberger, D. R., & Chen, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2077-08.2008 · Cited by 288 · see citing works
Monoamine Oxidase in Neuropsychiatry and Behavior
Shih, J. C., & Thompson, R. F. (1999) · The American Journal of Human Genetics · doi:10.1086/302562 · Cited by 250 · see citing works
Genetic approaches to addiction: genes and alcohol
Ducci, F., & Goldman, D. A. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02203.x · Cited by 245 · see citing works
Tolcapone improves cognition and cortical information processing in normal human subjects
Apud, J. A., Mattay, V., Chen, J., Kolachana, B. S., Callicott, J. H., Rasetti, R., Alce, G., Iudicello, J. E., Akbar, N., Egan, M. F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301227 · Cited by 242 · see citing works
Functional and clinical neuroanatomy of morality.
Fumagalli, M., & Priori, A. (2012) · Brain : a journal of neurology · doi:10.1093/brain/awr334 · Cited by 232 · see citing works
Krugel, L. K., Biele, G., Mohr, P. N. C., Li, S.-C., & Heekeren, H. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905191106 · Cited by 229 · see citing works
Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia
Gray, J. A., & Roth, B. L. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm074 · Cited by 225 · see citing works
Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition
Meyer‐Lindenberg, A., Straub, R. E., Lipska, B. K., Verchinski, B. A., Goldberg, T. E., Callicott, J. H., Egan, M. F., Huffaker, S., Mattay, V. S., Kolachana, B. S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30413 · Cited by 226 · see citing works
Prepulse inhibition and genetic mouse models of schizophrenia
Powell, S. B., Zhou, X., & Geyer, M. A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.021 · Cited by 218 · see citing works
Craddock, N., Owen, M. J., & O'Donovan, M. C. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001808 · Cited by 216 · see citing works
Working Memory Contributions to Reinforcement Learning Impairments in Schizophrenia
Collins, A. G. E., Brown, J. K., Gold, J. M., Waltz, J. A., & Frank, M. J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0989-14.2014 · Cited by 214 · see citing works
Genetics of human aggressive behaviour
Craig, I. W., & Halton, K. E. (2009) · Human Genetics · doi:10.1007/s00439-009-0695-9 · Cited by 213 · see citing works
Gadad, B. S., Jha, M. K., Czysz, A., Furman, J. L., Mayes, T. L., Emslie, M. P., & Trivedi, M. H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.07.001 · Cited by 205 · see citing works
The Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities
Carpenter, W. T., & Koenig, J. I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301639 · Cited by 210 · see citing works
Maternal programming of defensive responses through sustained effects on gene expression
Zhang, T.-Y., Bagot, R., Parent, C., Nesbitt, C., Bredy, T. W., Caldji, C., Fish, E., Anisman, H., Szyf, M., & Meaney, M. J. (2006) · Biological Psychology · doi:10.1016/j.biopsycho.2006.01.009 · Cited by 206 · see citing works
Thapar, A., Langley, K., Fowler, T., Rice, F. J., Turic, D., Whittinger, N., Aggleton, J. P., van den Bree, M. B. M., Owen, M. J., & O’Donovan, M. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1275 · Cited by 203 · see citing works
Genetic animal models: focus on schizophrenia
Gainetdinov, R. R., Mohn, A. R., & Caron, M. G. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01886-5 · Cited by 201 · see citing works
Tunbridge, E., Weickert, C., Kleinman, J., Herman, M., Chen, J., Kolachana, B., Harrison, P., & Weinberger, D. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl032 · Cited by 197 · see citing works
Targeted gene mutation approaches to the study of anxiety-like behavior in mice
Holmes, A. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00012-4 · Cited by 198 · see citing works
COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET
Slifstein, M., Kolachana, B. S., Simpson, E. H., Tabares, P., Cheng, B., Duvall, M., Frankle, W. G., Weinberger, D. R., Laruelle, M. A., & Abi‐Dargham, A. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.19 · Cited by 195 · see citing works
Neurogenetics and Pharmacology of Learning, Motivation, and Cognition
Frank, M. J., & Fossella, J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.96 · Cited by 191 · see citing works
Dopaminergic Genes Predict Individual Differences in Susceptibility to Confirmation Bias
Doll, B. B., Hutchison, K. E., & Frank, M. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6486-10.2011 · Cited by 184 · see citing works
Ursini, G., Bollati, V., Fazio, L., Porcelli, A., Iacovelli, L., Catalani, A., Sinibaldi, L., Gelao, B., Romano, R., Rampino, A., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6631-10.2011 · Cited by 188 · see citing works
Rujescu, D., Giegling, I., Gietl, A. F., Hartmann, A. M., & Möller, H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01831-0 · Cited by 189 · see citing works
Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice
Käenmäki, M., Tammimäki, A., Myöhänen, T. T., Pakarinen, K., Amberg, C., Karayiorgou, M., Gogos, J. A., & Männistö, P. T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06889.x · Cited by 188 · see citing works
Self-citationGenetic determinants of aggression and impulsivity in humans
Pavlov, K. A., Chistiakov, D. A., & Chekhonin, V. P. (2012) · Journal of Applied Genetics · doi:10.1007/s13353-011-0069-6 · Cited by 184 · see citing works
The pipeline and future of drug development in schizophrenia
Gray, J. A., & Roth, B. L. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002062 · Cited by 181 · see citing works
Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap
Pratt, J. A., Winchester, C. L., Dawson, N., & MORRIS, B. J. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3649 · Cited by 189 · see citing works
The neurobiological basis of human aggression: A review on genetic and epigenetic mechanisms
Waltes, R., Chiocchetti, A. G., & Freitag, C. M. (2016) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32388 · Cited by 182 · see citing works
Volavka, J. (1999) · Journal of Neuropsychiatry · doi:10.1176/jnp.11.3.307 · Cited by 181 · see citing works
Paloyelis, Y., Asherson, P., Mehta, M. A., Faraone, S. V., & Kuntsi, J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.124 · Cited by 180 · see citing works
Williams‐Gray, C. H., Hampshire, A., Robbins, T. W., Owen, A. M., & Barker, R. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0774-07.2007 · Cited by 180 · see citing works
Brain catecholamine metabolism in catechol‐O‐methyltransferase (COMT)‐deficient mice
Huotari, M., Gogos, J. A., Karayiorgou, M., Koponen, O., Forsberg, M., Raasmaja, A., Hyttinen, J. M. T., & Männistö, P. T. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01856.x · Cited by 180 · see citing works
Self-citationNeurobehavioral foundation of environmental reactivity.
Moore, S. R., & Depue, R. A. (2015) · Psychological Bulletin · doi:10.1037/bul0000028 · Cited by 181 · see citing works
Is COMT a Susceptibility Gene for Schizophrenia?
Williams, H. J., Owen, M. J., & O’Donovan, M. C. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm019 · Cited by 178 · see citing works
- Authors
- Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M.
- Affiliations
- Hunter College (US)
- City University of New York (US)
- The Rockefeller University, New York, NY 10021; Columbia University, College of Physicians and Surgeons, Center for Neurobiology and Behavior, New York, NY 10032; and Hunter College, New York, NY 10021
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-08-18
- Volume
- 95
- Issue
- 17
- Pages
- 9991-9996
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC21449
- OpenAlex
- W2105837661
- Cited by
- 864
- References
- 41
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 11 · 2023: 8 · 2022: 13 · 2021: 8 · 2020: 18 · 2019: 19 · 2018: 32 · 2017: 25 · 2016: 31 · 2015: 40 · 2014: 47 · 2013: 45 · 2012: 50
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- catechol-O-methyltransferase, catecholamine metabolism, dopamine, sexual dimorphism, anxiety-like behavior, aggression, sensorimotor gating, emotional reactivity, 22q11.2 deletion syndrome, striatum, frontal cortex, hypothalamus
- MeSH terms
- Amino Acid Sequence, Animals, Behavior, Animal, Mental Disorders, Brain, Catechol O-Methyltransferase, Catecholamines, Disease Models, Animal, Female, Heterozygote, Homozygote, Humans, Male, Mice, Inbred C57BL, Molecular Sequence Data, Phenotype, Sex Characteristics, Sequence Homology, Amino Acid, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review